Comfortable leader
12 companies value 18 bn revenue 7.6 bn margin -8.6% free cash flow 0.5 bn avg. score 1.7
HNGE holds 47.6% of the group's value, 1.3x the runner-up · HIMS leads the industry without being the largest
| Rank | Ticker | Company | Share | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HNGE | Hinge Health, Inc. United States · score 5.9 | 48% | 8.4 bn | 0.7 bn | 15.1% | 0.3 bn | 3.5% | — | Digital treatment for joint and muscle pain · California — revenue of $720m | |
| 2 | HIMS | Hims & Hers Health United States · score 2.2 | 37% | 6.6 bn | 2.6 bn | -5.5% | 0.1 bn | 0.9% | — | Telehealth and subscription medications · Largest US direct-to-consumer telehealth platform | |
| 3 | OMDA | Omada Health, Inc. United States · score 4.0 | 6% | 1.1 bn | 0.3 bn | 1.4% | 0.0 bn | 2.1% | — | Between-visit virtual care for health plans and employers · California — revenue of $310m | |
| 4 | TDOC | Teladoc Health United States · score 4.2 | 6% | 1.0 bn | 2.5 bn | -7.1% | 0.3 bn | 24.4% | — | Telehealth and virtual care · Pioneer in employer telehealth; growth has stalled | |
| 5 | AMWL | American Well United States · score 0.0 | 1% | 0.2 bn | 0.2 bn | -35.7% | -0.0 bn | -12.6% | — | Telehealth and digital care platform · Telehealth platform used by hospitals and the military health system | |
| 6 | WW | WW INTERNATIONAL, INC. United States · score 0.0 | 1% | 0.1 bn | 0.7 bn | -14.8% | 0.0 bn | -3.0% | — | Weight loss program with community and app · New York — revenue of $678m | |
| 7 | LFMD | LifeMD, Inc. United States · score 2.2 | 1% | 0.1 bn | 0.2 bn | 0.1% | -0.0 bn | -10.2% | 2.9% | Direct-to-patient telehealth and pharmacy · New York — revenue of $192m | |
| 8 | DCGO | DocGo Inc. United States · score 0.9 | 0% | 0.0 bn | 0.3 bn | -65.3% | -0.0 bn | -102.5% | 4.8% | Mobile health services and virtual care · New York — revenue of $295m | |
| 9 | DRIO | DarioHealth Corp. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -169.9% | -0.0 bn | -57.9% | — | Digital whole-person health platform · New York — revenue of $21m | |
| 10 | MGRX | MANGOCEUTICALS, INC. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -48x | 0.0 bn | -64.8% | — | Men's health by telemedicine · Texas | |
| 11 | POM | POMDOCTOR Ltd China · score 0.5 | — | — | 0.1 bn | -32.7% | -0.0 bn | — | — | — | Platform connecting patients with healthcare providers · China — revenue of $57m |
| 12 | MNDR | Mobile-health Network Solutions Singapore · score 1.0 | — | — | 0.0 bn | -35.3% | 0.0 bn | — | — | Telemedicine and digital health ecosystem, from Singapore · Singapore — revenue of $7m |
Other industries in the same sector
- Sector overview
- Large-cap pharmaceuticals 9 companies
- Biotechnology 57 companies
- European pharmaceuticals 5 companies
- Lab tools and consumables 37 companies
- Health insurance and services 17 companies
- Medical devices 87 companies
- Specialty pharmaceuticals 77 companies
- Pharmaceutical distribution 7 companies
- Clinical-stage pharmaceuticals 251 companies
- Robotic surgery and advanced medtech 9 companies
- Hospitals 23 companies
- Emerging biotech 5 companies
and 22 industries more
- Molecular testing and advanced diagnostics 42 companies
- Vaccines and mRNA 14 companies
- Clinical-stage biotech 200 companies
- Generics and biosimilars 10 companies
- Animal health 7 companies
- Contract research (CRO) 10 companies
- Consumer health (OTC) 4 companies
- Healthcare software 18 companies
- Rehabilitation and home care 15 companies
- Genomics and sequencing 9 companies
- Structural heart 8 companies
- Ophthalmology 12 companies
- Medical imaging and hospital equipment 16 companies
- Diagnostic labs 6 companies
- Medical and dental supply distribution 3 companies
- Diabetes monitoring 9 companies
- Pharmaceutical royalties 5 companies
- Respiratory and sleep therapy 9 companies
- Orthopedic implants 17 companies
- Dialysis 3 companies
- Dental 4 companies
- Medical and recreational cannabis 16 companies
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.